๐ฐ Allo News
Page 7 - Allo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Allo. Real-time updates on events, politics, business and more.
September 29, 2023
Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its target price cut by JPMorgan Chase & Co. from $11.00 to $9.00 in a research report sent to investors on Monday morning, Marketbeat.com reports. They currently have an overweight rating on the stock. ALLO has been the subject of a number of other research reports. Oppenheimer reaffirmed […]
September 29, 2023
Martin Solveig has enlisted Stefflon Don for a new single, I Don't Wanna Work....
September 29, 2023
The Allo Allo star, 72, shared the upsetting news thatย Suzie had passed away and thank the hundreds of people who had paid their respects at her funeral.
September 29, 2023
Emmerdale actress Vicki Michelle has been left devastated after the death of her younger sister Suzie and has paid tribute to her on social media.
September 19, 2023
Like us on FacebookLearning Curves is sponsored by: Allo Communications, Kearney Public Schools, BD Construction
September 5, 2023
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and nine have given a buy recommendation […]
August 10, 2023
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Investment analysts at HC Wainwright upped their Q3 2023 earnings per share estimates for shares of Allogene Therapeutics in a report issued on Monday, August 7th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of ($0.48) for the quarter, up […]
August 9, 2023
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Investment analysts at William Blair boosted their Q3 2023 earnings estimates for Allogene Therapeutics in a research note issued on Thursday, August 3rd. William Blair analyst S. Corwin now anticipates that the company will post earnings per share of ($0.53) for the quarter, up from their prior […]
August 8, 2023
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $4.27 and last traded at $4.31, with a volume of 1199577 shares trading hands. The stock had previously closed at $4.59. Analyst Upgrades and Downgrades ALLO has been the topic […]
July 16, 2023
Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its price target decreased by Truist Financial from $20.00 to $18.00 in a research report released on Wednesday, FlyOnTheWall reports. A number of other equities analysts also recently commented on ALLO. EF Hutton Acquisition Co. I reaffirmed a buy rating and set a $15.00 price objective on shares […]